FPI phase II RCC

  • 09:07

Immunicum AB (publ) today announced that the first patient has been included in the international phase II study with the therapeutic cancer vaccine INTUVAX for the treatment of patients with metastatic kidney cancer.

Read the press release here: Press release 150505 – FPI